血清NF-κB、Nrf2水平对2型糖尿病肾病患者预后的预测价值

doi:10.3969/j.issn.1671-7171.2023.12.034

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1303 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨血清核因子-κB(NF-κB)、核因子E2相关因子(Nrf2)水平对2型糖尿病肾病患者预后的预测价值。【方法】回顾性分析2020年4月至2022年4月陕西省核工业二一五医院收治的118例2型糖尿病肾病患者的临床资料,根据患者预后情况分为预后不佳组(肾功能衰竭、尿毒症或死亡,n=48)和预后良好组(n=70)。分析2型糖尿病肾病患者预后的影响因素及NF-κB、Nrf2对2型糖尿病肾病患者预后的预测价值。【结果】预后不佳组NF-κB、血肌酐(Scr)、尿蛋白排泄率(UAER)水平均高于预后良好组,Nrf2、肾小球滤过率(eGFR)均低于预后良好组(P<0.05)。Logistic分析结果显示:NF-κB升高、Scr升高、UAER升高、Nrf2降低、eGFR降低均是2型糖尿病肾病患者预后不佳的危险因素(P<0.05)。受试者工作特征(ROC)曲线分析显示:血清NF-κB、Nrf2及其联合预测2型糖尿病肾病患者预后的曲线下面积(AUC)分别为0.713、0.706、0.801。【结论】血清NF-κB联合Nrf2对2型糖尿病肾病患者预后的预测效能良好。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张勇
	王新磊

关键词 ：糖尿病,2型/并发症, 糖尿病肾病/并发症, 转录因子/血液, NF-κB/血液

Abstract：【Objective】To explore the prognostic value of serum levels of nuclear factor-κB (NF-κB) and nuclear factor E2 related factor (Nrf2) in patients with type 2 diabetes nephropathy.【Methods】The clinical data of 118 patients with type 2 diabetes nephropathy admitted to the NO.215 Hospital of Shaanxi Nuclear Industry from April 2020 to April 2022 were retrospectively analyzed. According to the prognosis of patients, they were divided into poor prognosis group (renal failure, uremia or death, n=48) and good prognosis group (n=70). The prognostic factors of type 2 diabetes nephropathy patients and the predictive value of NF-κB and Nrf2 on the prognosis of type 2 diabetes nephropathy patients were analyzed.【Results】The levels of NF-κB, serum creatinine (Scr), and urinary protein excretion rate (UAER) in the poor prognosis group were higher than those in the good prognosis group, while Nrf2 and glomerular filtration rate (eGFR) were lower than those in the good prognosis group (P<0.05). Logistic analysis showed that the increase of NF-κB, Scr, UAER, Nrf2 and eGFR were all risk factors for poor prognosis of type 2 diabetes nephropathy patients (P<0.05). The analysis of ROC curve of subjects showed that the area under the curve (AUC) of serum NF-κB, Nrf2 and their combination to predict the prognosis of type 2 diabetes nephropathy patients were 0.713, 0.706 and 0.801, respectively. 【Conclusion】The combination of serum NF-κB and Nrf2 is effective in predicting the prognosis of patients with type 2 diabetes nephropathy.

Key words： Diabetes Mellitus, Type 2/CO Diabetic Nephropathies/CO Transcription Factors/BL NF-kappa B/BL

收稿日期: 2023-06-26

中图分类号:

R587.1

通讯作者: *E-mail:wxlmedicine@163.com

引用本文:

张勇, 王新磊. 血清NF-κB、Nrf2水平对2型糖尿病肾病患者预后的预测价值[J]. 医学临床研究, 2023, 40(12): 1940-1942.
ZHANG Yong,WANG Xinlei. Prognostic Value of Serum NF-κB and Nrf2 Levels in Type 2 Diabetes Nephropathy. JOURNAL OF CLINICAL RESEARCH, 2023, 40(12): 1940-1942.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2023.12.034 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2023/V40/I12/1940

[1] ASHRAFIZADEH M, AHMADI Z, MOHAMMADINEJAD R, et al. Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury[J].Curr Mol Med,2020,20(2):116-133.
[2] 刘东欣,江琴. 2型糖尿病肾病患者血清NF-κB、MDA、FFA、visfatin水平变化及肾功能状况分析[J].中国中西医结合肾病杂志,2022,23(9):827-829.
[3] 王露,李见. 2型糖尿病肾病患者血清NF-κB、MDA水平及其与肾功能的关系探讨[J].中国现代医学杂志,2022,32(3):21-25.
[4] 中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志,2021,37(3):255-304.
[5] KIM M N, MOON J H, CHO Y M. Sodium-glucose cotransporter-2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body-induced NRF2 activation[J].Diabetes Obes Metab,2021,23(11):2561-2571.
[6] RUSH B M, BONDI C D, STOCKER S D, et al. Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice[J].Kidney Int,2021,99(1):102-116.
[7] 杨柳,马伟,王业秋,等. 补阳还五汤对糖尿病肾病大鼠肾脏氧化应激及NF-κB通路的影响[J].国际中医中药杂志,2022,44(9):1012-1016.
[8] 陈艳霞,涂卫平,房向东,等. 益肾化湿颗粒通过RhoA/ROCK1信号通路对糖尿病肾病炎症的影响[J].重庆医学,2022,51(18):3074-3078.
[9] SHUKLA R, BANERJEE S, TRIPATHI Y B. Pueraria tuberosa extract inhibits iNOS and IL-6 through suppression of PKC-alpha and NF-kB pathway in diabetes-induced nephropathy[J].J Pharm Pharmacol,2018,70(8):1102-1112.
[10] 罗阳燕,高芳,魏梦婷,等. 鸢尾素对糖尿病肾病大鼠p38 MAPK/NF-κB通路及肾损伤的影响[J].中国中西医结合肾病杂志,2022,23(9):764-767.
[11] 金依依,周科挺,杨成成,等. 蛇床子素抑制NF-κB和p38/MAPK改善糖尿病诱导的肾脏损伤[J].中国临床药理学与治疗学,2022,27(6):622-631.
[12] 路琪,李菲菲,孙虹燕. 薯蓣皂苷对糖尿病肾病大鼠TLR4/NF-κB/TNF-α通路及肾间质淋巴细胞浸润的影响[J].中国免疫学杂志,2022,38(7):816-821.
[13] POTTETI H R, NOONE P M, TAMATAM C R, et al. Nrf2 mediates hypoxia-inducible HIF1alpha activation in kidney tubular epithelial cells[J].Am J Physiol Renal Physiol,2021,320(3):F464-F474.
[14] 王翯,辛欢欢,田茜,等. 2型糖尿病肾病患者血浆纤溶酶原激活物抑制剂1及核因子E2相关因子2水平变化及临床意义[J].中华保健医学杂志,2022,24(4):311-314.
[15] 黄丹,胡韬韬,陈丹. 血清高迁移率族蛋白B1与糖尿病肾病病人肾功能、炎症因子及氧化应激指标的相关性研究[J].蚌埠医学院学报,2022,47(8):1021-1025.
[16] 张伟开,张玲. 糖尿病肾病患者SOD-Mn基因多态性与肾功能、氧化性损伤的相关性[J].海南医学院学报,2018,24(14):1311-1314.